CN Patent

CN113461665B — 二芳基衍生物及其制备方法和用途

Assigned to Chengdu Zeling Biopharmaceutical Technology Co Ltd · Expires 2023-05-19 · 3y expired

What this patent protects

本发明属于化学医药领域，具体涉及二芳基衍生物及其制备方法和用途。本发明提供了一种二芳基衍生物及其制备方法和用途，其结构式如式Ⅰ所示。此外，本发明还提供了上述二芳基衍生物及其制备方法和用途。本发明化合物能够有效治疗肿瘤或/和皮肤疾病，可以用于制备治疗肿瘤或/和皮肤疾病的药物。

USPTO Abstract

本发明属于化学医药领域，具体涉及二芳基衍生物及其制备方法和用途。本发明提供了一种二芳基衍生物及其制备方法和用途，其结构式如式Ⅰ所示。此外，本发明还提供了上述二芳基衍生物及其制备方法和用途。本发明化合物能够有效治疗肿瘤或/和皮肤疾病，可以用于制备治疗肿瘤或/和皮肤疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN113461665B
Jurisdiction
CN
Classification
—
Expires
2023-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Zeling Biopharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.